Clinical Microbiology and Infection

Papers
(The H4-Index of Clinical Microbiology and Infection is 56. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
COVID-19 in special populations735
Primary antifungal prophylaxis after haematopoietic stem cell transplantation: will the search for perfection become the enemy of good?648
Corrigendum to “Dynamic transmission models and economic evaluations of pneumococcal conjugate vaccines: a quality appraisal and limitations” [Clin Microbiol and Infect 26 (1) (2020) 60–70]431
Cefiderocol for resistant Gram negatives: linking in vitro activity with clinical effectiveness424
Outside Front Cover416
Should multiplex PCR testing be integrated into antimicrobial stewardship programs for paediatric community-acquired pneumonia in the emergency department?274
Measuring the impact of hospitalization for infectious diseases on the quality of life of older patients in four European countries: the AEQUI longitudinal matched cohort study (2020–2023)254
Exploring the limits of interferon-γ releasing assay screening in large-scale populations183
What is the evidence base of used aggregated antibiotic resistance percentages to change empirical antibiotic treatment? A scoping review173
Intra-host non-synonymous diversity at a neutralizing antibody epitope of SARS-CoV-2 spike protein N-terminal domain158
Myxovirus resistance protein A for discriminating between viral and bacterial lower respiratory tract infections in children – The TREND study157
Respiratory syncytial virus in adults with comorbidities: an update on epidemiology, vaccines, and treatments156
Re: ‘Dosing and route of administration of clindamycin given in combination with rifampicin’ by Magreault et al.148
Acquired fluconazole resistance and genetic clustering in Diutina (Candida) catenulata from clinical samples141
Re: what is the role of epidemiological investigations in human Campylobacter outbreaks in the One Health and whole-genome sequencing era in Denmark?136
Mycotic aneurysm of the infrarenal abdominal aorta infected by Mycoplasma hyorhinis diagnosed with direct 16S ribosomal DNA sequencing127
Fecal pharmacokinetics/pharmacodynamics characteristics of fidaxomicin and vancomycin against Clostridioides difficile infection elucidated by in vivo feces-based infectious evaluation models108
Re: Compromised access to antibiotics: addressing paediatric challenges in availability and responsible use107
How to: Diagnose inborn errors of intrinsic and innate immunity to viral, bacterial, mycobacterial, and fungal infections104
Which trial do we need? Doxycycline in combination with ceftriaxone for the treatment of community-acquired pneumonia102
‘Introducing new antibiotics for multidrug-resistant bacteria: obstacles and the way forward’ – author's response102
Pathogen and host determinants of extrapulmonary tuberculosis among 1035 patients in Frankfurt am Main, Germany, 2008–2023100
Expected phenotypes and expert rules are important complements to antimicrobial susceptibility testing99
Post-acute COVID-19 syndrome: a new tsunami requiring a universal case definition91
Re: ‘Association between pertactin-producing Bordetella pertussis and fulminant pertussis in infants: a multicentre study in France, 2008–2019’ by Leroux et al.89
Re: Diagnostic limitations and challenges in current clinical guidelines and potential application of metagenomic sequencing to manage pulmonary invasive fungal infections in patients with haematologi86
Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimab86
The diagnostic value of serum Borrelia burgdorferi antibodies and seroconversion after Lyme neuroborreliosis, a nationwide observational study84
‘Scope and aims of ESCMID guidelines’ by Scudeller et al.84
Large language models for antibiotic prescribing—moving the needle from ‘parlour trick’ to practical tool84
TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylate84
The importance of patient information and informed consent for unlicensed phage therapy81
The interplay between Epstein-Barr Virus and Cytomegalovirus reactivation following allogeneic hematopoietic cell transplantation in the era of primary CMV prophylaxis79
Assessment of BIV1-CovIran inactivated vaccine–elicited neutralizing antibody against the emerging SARS-CoV-2 variants of concern78
Antimicrobial susceptibility of Mycobacterium abscessus and treatment of pulmonary and extra-pulmonary infections78
A randomised trial of simultaneous versus sequential pneumococcal vaccination in elderly75
Re: ‘The relative effectiveness of a high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccines in older adults in France: a retrospective cohort study during the 2071
Has the COVID-19 pandemic wiped out the seasonality of outpatient antibiotic use and influenza activity? A time-series analysis from 2014 to 202170
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review68
European society of clinical microbiology and infectious diseases guidelines for antimicrobial stewardship in emergency departments (endorsed by European association of hospital pharmacists)68
Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis68
Acute cough in outpatients: what causes it, how long does it last, and how severe is it for different viruses and bacteria?67
Non-biomedical factors affecting antibiotic use in the community: a mixed-methods systematic review and meta-analysis63
Pharmacokinetics/pharmacodynamics of phage therapy: a major hurdle to clinical translation63
Re: ‘Heightened incidence of adverse events associated with a live attenuated varicella vaccine strain that lacks critical genetic polymorphisms in ORF62’ by Kim et al.62
Oral step-down with β-lactams for uncomplicated Enterobacterales bacteraemia61
A chronic infectious bladder stone causing an obstructive emphysematous cystitis60
Evaluating stratified T-SPOT.TB results for diagnostic accuracy in tuberculosis disease: a retrospective cohort study with sensitivities, specificities, and predictive values59
Anti-SARS-CoV-2 antibody response after 2 and 3 doses of BNT162b2 mRNA vaccine in patients with lymphoid malignancies59
One- versus two-specimen Xpert strategy to discontinue airborne isolation in suspected pulmonary tuberculosis: systematic review and meta-analysis58
Comparison of β-D-Glucan levels between Candida auris and other Candida species at the time of candidaemia: a retrospective study58
Which trial do we need? Three-day course of antibiotics for acute pyelonephritis in immunocompetent women57
In vitro activity of the novel siderophore cephalosporin, cefiderocol, in Gram-negative pathogens in Europe by site of infection57
Bacterial and fungal bloodstream infections in solid organ transplant recipients: results from a Danish cohort with nationwide follow-up57
Which trial do we need? Next-generation sequencing to individualize therapy in Staphylococcus aureus bacteraemia56
Which trial do we need? Combination treatment of Pneumocystis jirovecii pneumonia in non-HIV infected patients56
0.1318690776825